Jenburkt Pharmaceuticals Limited Buyback 2022
(i) Headquartered in Mumbai, India – Jenburkt Pharmaceuticals Ltd. has worked its way up from the solid foundation of the group laid by Late Shri Nandlal Mulji Bhuta in the 20th Century, established a deeply-trusted Pharmaceutical organization by Mr. Hemendra Nandlal Bhuta and Mr. Uttam Nandlal Bhuta.
(ii) Presently, Jenburkt manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. With over 850+ committed team members across functions pan-India, we promote all our 85 brands across 100,000+ doctors regularly. Our company has more than 1,000 stockists and our reach extends to 400,000+ pharmacies across the globe.
(iii) The organization caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Our products are also being exported to 13 countries globally.
(iv) In addition, Jenburkt has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the company has strong manufacturing facilities to cater to both the domestic and international market.
Buy Back Offer Deal:
|Buyback Type:||Open Market|
|Buyback Offer Amount:||₹ 11.60 Cr|
|Date of Board Meeting approving the proposal:||Dec 01 2022|
|Date of Public Announcement:||Dec 01 2022|
|Buyback Offer Size:||3.60%|
|Buyback Number of Shares:||1,65,242|
|Price Type:||Open Market|
|Buyback Price:||₹ 702 Per Equity Share|
Details of Buyback:
Salient financial parameters:
|Particulars (In Cr)||Mar 2018||Mar 2019||Mar 2020||Mar 2021||Mar 2022|
|Other Income +||3||3||4||4||5|
|Profit before tax||25||27||21||22||30|
|EPS in Rs||37.5||43.14||32.4||35.95||48.59|